S

Sarepta Therapeutics
D

SRPT

113.370
USD
2.87
(2.60%)
Market Open
Volume
8,413
EPS
2
Div Yield
-
P/E
74
Market Cap
10,829,062,721
OverviewSignalsIdeasNews
Related Instruments
    BIIB
    BIIB
    -4.840
    (-2.94%)
    160.000 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    IONS
    -2.970
    (-7.97%)
    34.290 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    R
    RGLS
    -0.06500
    (-4.32%)
    1.44000 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    454.61 USD
    More
News

Title: Sarepta Therapeutics

Sector: Healthcare
Industry: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.